In the initial phase of CRC tumorigenesis, deletions in tumor suppressor gene SMAD4 promoted tumorigenesis by precluding functional TGF-β signaling, thus demonstrating the protective nature of the TGF-β pathway in early stage tumors [10, 41]. The gene discussed is SMAD4; the disease is colorectal carcinoma.